In this context, mutations in actin-binding proteins that are specifically expressed in podocytes, like α-actinin-4 (7) or anillin (8), induce focal segmental glomerulosclerosis (FSGS). The gene discussed is ANLN; the disease is focal segmental glomerulosclerosis.